Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
Top Cited Papers
- 1 June 2012
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 12 (6), 488-496
- https://doi.org/10.1016/s1473-3099(12)70064-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Poor quality vital anti-malarials in Africa - an urgent neglected public health priorityMalaria Journal, 2011
- Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countriesThe Analyst, 2010
- Deamplification of pfmdr1 -Containing Amplicon on Chromosome 5 in Plasmodium falciparum Is Associated with Reduced Resistance to Artelinic Acid In VitroAntimicrobial Agents and Chemotherapy, 2010
- Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence MechanismAntimicrobial Agents and Chemotherapy, 2010
- High Heritability of Malaria Parasite Clearance Rate Indicates a Genetic Basis for Artemisinin Resistance in Western CambodiaThe Journal of Infectious Diseases, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR – implications for therapeutic failure and drug resistanceMalaria Journal, 2009
- Quality of anti-malarial drugs provided by public and private healthcare providers in south-east NigeriaMalaria Journal, 2009
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008